We are live on
!
Find out more
OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
4 hedge funds and large institutions have $2.55M invested in Oasmia Pharmaceutical AB in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
12% less capital invested
Capital invested by funds: $2.89M → $2.55M (-$346K)
33% less funds holding
Funds holding: 6 → 4 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.83K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$657K |
| 2 |
Jane Street
New York
|
-$40K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7K |
| 4 |
Morgan Stanley
New York
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $2.02M | -$657K | -185,302 | -28% |
|
|
SCM
2
Sio Capital Management
New York
| $523K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3K | +$2.83K | +800 | +20,000% |
|
|
4
Jane Street
New York
| – | -$40K | -10,590 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$7K | -1,900 | Closed |
|
|
6
Morgan Stanley
New York
| – | -$4 | -1 | -25% |
|